These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37209920)

  • 1. Elevated PSPC1 and KDM5C expression indicates poor prognosis in prostate cancer.
    Lemster AL; Weingart A; Bottner J; Perner S; Sailer V; Offermann A; Kirfel J
    Hum Pathol; 2023 Aug; 138():1-11. PubMed ID: 37209920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy.
    Stein J; Majores M; Rohde M; Lim S; Schneider S; Krappe E; Ellinger J; Dietel M; Stephan C; Jung K; Perner S; Kristiansen G; Kirfel J
    Am J Pathol; 2014 Sep; 184(9):2430-7. PubMed ID: 25016185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone Demethylase KDM5C Drives Prostate Cancer Progression by Promoting EMT.
    Lemster AL; Sievers E; Pasternack H; Lazar-Karsten P; Klümper N; Sailer V; Offermann A; Brägelmann J; Perner S; Kirfel J
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KDM5C is transcriptionally regulated by BRD4 and promotes castration-resistance prostate cancer cell proliferation by repressing PTEN.
    Hong Z; Wu G; Xiang ZD; Xu CD; Huang SS; Li C; Shi L; Wu DL
    Biomed Pharmacother; 2019 Jun; 114():108793. PubMed ID: 30921702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression.
    Ji X; Jin S; Qu X; Li K; Wang H; He H; Guo F; Dong L
    BMC Cancer; 2015 Oct; 15():801. PubMed ID: 26503415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma.
    Qian X; Bao ZM; Yao D; Shi Y
    Kaohsiung J Med Sci; 2022 May; 38(5):437-446. PubMed ID: 35080113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PSPC1-interchanged interactions with PTK6 and β-catenin synergize oncogenic subcellular translocations and tumor progression.
    Lang YD; Chen HY; Ho CM; Shih JH; Hsu EC; Shen R; Lee YC; Chen JW; Wu CY; Yeh HW; Chen RH; Jou YS
    Nat Commun; 2019 Dec; 10(1):5716. PubMed ID: 31844057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5.
    Lin CY; Jan YJ; Kuo LK; Wang BJ; Huo C; Jiang SS; Chen SC; Kuo YY; Chang CR; Chuu CP
    Cancer Sci; 2018 Nov; 109(11):3564-3574. PubMed ID: 30142696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive Value of
    Chen XJ; Ren AQ; Zheng L; Zheng ED
    Front Immunol; 2021; 12():664847. PubMed ID: 33953726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
    Chang S; Yim S; Park H
    Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSPC1 mediates TGF-β1 autocrine signalling and Smad2/3 target switching to promote EMT, stemness and metastasis.
    Yeh HW; Hsu EC; Lee SS; Lang YD; Lin YC; Chang CY; Lee SY; Gu DL; Shih JH; Ho CM; Chen CF; Chen CT; Tu PH; Cheng CF; Chen RH; Yang RB; Jou YS
    Nat Cell Biol; 2018 Apr; 20(4):479-491. PubMed ID: 29593326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Prognosis Value of PSPC1 Expression in Nasopharyngeal Cancer.
    He H; Zhang L; Lin K; Huang Z; Zhou Y; Lin S; Su Y; Pan J
    Cancer Manag Res; 2021; 13():3281-3291. PubMed ID: 33883941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
    Mohankumar K; Shrestha R; Safe S
    Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-181a retards nasopharyngeal carcinoma development by mediating KDM5C.
    Liu J; Zhu M; Tang Q
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):2867-2877. PubMed ID: 34218325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular Carcinoma and Nuclear Paraspeckles: Induction in Chemoresistance and Prediction for Poor Survival.
    Kessler SM; Hosseini K; Hussein UK; Kim KM; List M; Schultheiß CS; Schulz MH; Laggai S; Jang KY; Kiemer AK
    Cell Physiol Biochem; 2019; 52(4):787-801. PubMed ID: 30946555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, Synthesis, and Biological Evaluation of Lysine Demethylase 5 C Degraders.
    Iida T; Itoh Y; Takahashi Y; Yamashita Y; Kurohara T; Miyake Y; Oba M; Suzuki T
    ChemMedChem; 2021 May; 16(10):1609-1618. PubMed ID: 33470543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
    Guo J; Wang M; Wang Z; Liu X
    PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of histone lysine demethylases in prostate cancer.
    Crea F; Sun L; Mai A; Chiang YT; Farrar WL; Danesi R; Helgason CD
    Mol Cancer; 2012 Aug; 11():52. PubMed ID: 22867098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.